Screener
CONMED CNMD Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Shareholders' equity: | ||
| Preferred stock, par value $0.01 per share; | ||
| authorized 500,000 shares; none outstanding | — | — |
| Common stock, par value $0.01 per share;100,000,000 shares authorized; 31,299,194 sharesissued in 2026 and 2025, respectively | 313 | 313 |
| Paid-in capital | 513,464 | 503,200 |
| Retained earnings | 625,665 | 588,766 |
| Accumulated other comprehensive loss | (43,372) | (46,295) |
| Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectively | (54,680) | (12,887) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's common stock, par value (in dollars per share)?
- CONMED (CNMD) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
- How has CONMED's common stock, par value (in dollars per share) changed year-over-year?
- CONMED's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for CONMED's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), CONMED's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
Ask your AI about CONMED's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude